monthly return from 2020 vktx

Viking Therapeutics (VKTX) had its best month since 2020 in February 2024, returning 217.1%.

ASSET MONTH % RETURN
Viking Therapeutics (VKTX)
January 2020
-23.88%
Viking Therapeutics (VKTX)
February 2020
-6.92%
Viking Therapeutics (VKTX)
March 2020
-21.61%
Viking Therapeutics (VKTX)
April 2020
32.41%
Viking Therapeutics (VKTX)
May 2020
27.68%
Viking Therapeutics (VKTX)
June 2020
0.7%
Viking Therapeutics (VKTX)
July 2020
-1.96%
Viking Therapeutics (VKTX)
August 2020
-6.3%
Viking Therapeutics (VKTX)
September 2020
-14.16%
Viking Therapeutics (VKTX)
October 2020
-3.26%
Viking Therapeutics (VKTX)
November 2020
14.21%
Viking Therapeutics (VKTX)
December 2020
-12.44%
Viking Therapeutics (VKTX)
January 2021
28.25%
Viking Therapeutics (VKTX)
February 2021
-9.89%
Viking Therapeutics (VKTX)
March 2021
-2.84%
Viking Therapeutics (VKTX)
April 2021
0.63%
Viking Therapeutics (VKTX)
May 2021
-19.01%
Viking Therapeutics (VKTX)
June 2021
12.17%
Viking Therapeutics (VKTX)
July 2021
1.65%
Viking Therapeutics (VKTX)
August 2021
6.44%
Viking Therapeutics (VKTX)
September 2021
-5.42%
Viking Therapeutics (VKTX)
October 2021
-7.03%
Viking Therapeutics (VKTX)
November 2021
-9.23%
Viking Therapeutics (VKTX)
December 2021
-14.97%
Viking Therapeutics (VKTX)
January 2022
-20.56%